Morgan Stanley upgrades Nucor stock rating on capital spending outlook
Morgan Stanley upgraded Nucor's stock rating to Overweight from Equalweight, increasing its price target to $310 from $300. Despite the sector's expected strength, Nucor stands out among steel equities. Morgan Stanley forecasts a decline in capital expenditures, reducing from $3.4 billion in 2025 to $1.5 billion annually in 2027-2028.
This reduction in spending is expected to lead to a meaningful free cash flow inflection and increased flexibility for shareholder returns. Nucor's financial health has been rated as "GREAT" by InvestingPro, and the company has raised its dividend for 16 consecutive years while aggressively buying back shares. Analysts see approximately 23% upside potential with a positive bull-bear skew of 2.3:1.0.
Nucor's strong financial performance resulted in third-quarter earnings per share of $5.80, surpassing guidance, and EBITDA of $2.28 billion, slightly above consensus. UBS upgraded Nucor to Buy with a price target of $307, while KeyBanc increased its target to $301, both citing favorable steel pricing trends and improved earnings outlook.
Freedom Broker upgraded Nucor to Buy with a price target of $304, highlighting its third-quarter earnings beat. Wells Fargo raised its price target to $305, maintaining an Overweight rating due to market share gains and robust downstream performance.
Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.